共 25 条
- [2] BLUMENSTENGEL K, 1999, ANN HEMATOL S2, V77, P149
- [4] Bremer K, 1996, TUMORDIAGN THER, V17, P1
- [5] Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation [J]. BIOCHEMICAL PHARMACOLOGY, 2003, 66 (05) : 711 - 724
- [6] REPORTING OUTCOMES IN HODGKINS-DISEASE AND LYMPHOMA [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) : 1670 - 1672
- [7] HARRIS NL, 1994, BLOOD, V84, P1361
- [9] Results of a prospective randomised open label phase III study comparing rituximab plus mitoxantrone, chlorambucile, prednisolone chemotherapy (R-MCP) versus MCP alone in untreated advanced indolent non-Hodgkin's lymphoma (NHL) and mantle-cell-lymphoma (MCL). [J]. BLOOD, 2004, 104 (11) : 169A - 169A
- [10] HIDDEMANN W, 1999, KOMPENDIUM INT ONKOL, P279